These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29725470)

  • 1. Mutant monocyte chemoattractant protein-1 protein (7ND) inhibits osteoclast differentiation and reduces oral squamous carcinoma cell bone invasion.
    Luo S; Zhou C; Zhang J; Chen M; Li H; Zheng S; Quan J
    Oncol Lett; 2018 May; 15(5):7760-7768. PubMed ID: 29725470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCP-1 as a potential target to inhibit the bone invasion by oral squamous cell carcinoma.
    Quan J; Morrison NA; Johnson NW; Gao J
    J Cell Biochem; 2014 Oct; 115(10):1787-98. PubMed ID: 24905457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of different osteoclast phenotypes in the progression of bone invasion by oral squamous cell carcinoma.
    Quan J; Hou Y; Long W; Ye S; Wang Z
    Oncol Rep; 2018 Mar; 39(3):1043-1051. PubMed ID: 29286135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7ND protein exerts inhibitory effects on both osteoclast differentiation in vitro and lipopolysaccharide‑induced bone erosion in vivo.
    Long W; Quan J; Liu Y; Li J; Gong Q; Jiang H
    Mol Med Rep; 2020 Jul; 22(1):97-104. PubMed ID: 32377737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of E-cadherin by monocytes from tumour cells plays key roles in the progression of bone invasion by oral squamous cell carcinoma.
    Quan J; Du Q; Hou Y; Wang Z; Zhang J
    Oncol Rep; 2017 Aug; 38(2):850-858. PubMed ID: 28656299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation.
    Tatewaki H; Egashira K; Kimura S; Nishida T; Morita S; Tominaga R
    J Vasc Surg; 2007 Jun; 45(6):1236-43. PubMed ID: 17543688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels.
    Zhong L; Chen WQ; Ji XP; Zhang M; Zhao YX; Yao GH; Zhang PF; Zhang C; Zhang Y
    J Cell Mol Med; 2008 Dec; 12(6A):2362-71. PubMed ID: 18266972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant monocyte chemoattractant protein 1 protein attenuates migration of and inflammatory cytokine release by macrophages exposed to orthopedic implant wear particles.
    Yao Z; Keeney M; Lin TH; Pajarinen J; Barcay K; Waters H; Egashira K; Yang F; Goodman S
    J Biomed Mater Res A; 2014 Sep; 102(9):3291-7. PubMed ID: 24123855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria.
    Shimizu H; Maruyama S; Yuzawa Y; Kato T; Miki Y; Suzuki S; Sato W; Morita Y; Maruyama H; Egashira K; Matsuo S
    J Am Soc Nephrol; 2003 Jun; 14(6):1496-505. PubMed ID: 12761250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant CCL2 protein coating mitigates wear particle-induced bone loss in a murine continuous polyethylene infusion model.
    Nabeshima A; Pajarinen J; Lin TH; Jiang X; Gibon E; Córdova LA; Loi F; Lu L; Jämsen E; Egashira K; Yang F; Yao Z; Goodman SB
    Biomaterials; 2017 Feb; 117():1-9. PubMed ID: 27918885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression.
    Hounoki H; Sugiyama E; Mohamed SG; Shinoda K; Taki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Miyahara T
    Bone; 2008 Apr; 42(4):765-74. PubMed ID: 18242157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury.
    Furuichi K; Wada T; Iwata Y; Kitagawa K; Kobayashi K; Hashimoto H; Ishiwata Y; Tomosugi N; Mukaida N; Matsushima K; Egashira K; Yokoyama H
    J Am Soc Nephrol; 2003 Apr; 14(4):1066-71. PubMed ID: 12660342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer.
    Zhang Y; Rollins BJ
    Mol Cell Biol; 1995 Sep; 15(9):4851-5. PubMed ID: 7651403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory gene therapy for cardiovascular disease.
    Matoba T; Egashira K
    Curr Gene Ther; 2011 Dec; 11(6):442-6. PubMed ID: 22023473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection with a dominant-negative inhibitor of monocyte chemoattractant protein-1 gene improves cardiac function after 6 hours of cold preservation.
    Kajihara N; Morita S; Nishida T; Tatewaki H; Eto M; Egashira K; Yasui H
    Circulation; 2003 Sep; 108 Suppl 1():II213-8. PubMed ID: 12970235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
    Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
    Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1.
    Egashira K
    Hypertension; 2003 Mar; 41(3 Pt 2):834-41. PubMed ID: 12624005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant negative MCP-1 blocks human osteoclast differentiation.
    Morrison NA; Day CJ; Nicholson GC
    J Cell Biochem; 2014 Feb; 115(2):303-12. PubMed ID: 23996571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
    Cui N; Nomura T; Noma H; Yokoo K; Takagi R; Hashimoto S; Okamoto M; Sato M; Yu G; Guo C; Shibahala T
    Clin Cancer Res; 2005 Apr; 11(7):2713-9. PubMed ID: 15814653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys.
    Egashira K; Nakano K; Ohtani K; Funakoshi K; Zhao G; Ihara Y; Koga J; Kimura S; Tominaga R; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2563-8. PubMed ID: 17885211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.